Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: A retrospective analysis of the ACCENT i trial

Freddy Cornillie*, Stephen B. Hanauer, Robert H. Diamond, Jianping Wang, Kezhen L. Tang, Zhenhua Xu, Paul Rutgeerts, Séverine Vermeire

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

248 Scopus citations

Fingerprint Dive into the research topics of 'Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: A retrospective analysis of the ACCENT i trial'. Together they form a unique fingerprint.

Medicine & Life Sciences